BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38738332)

  • 1. Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostat-ectomy. A nationwide population-based study.
    Scilipoti P; Liedberg F; Garmo H; Wilberg Orrason A; Stattin P; Westerberg M
    Scand J Urol; 2024 May; 59():98-103. PubMed ID: 38738332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental prostate cancer in Asian men: high prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy.
    Yang X; Monn MF; Liu L; Liu Y; Su J; Lyu T; Gong Y; Wang L; Davidson DD; Cheng L
    Prostate; 2015 Jun; 75(8):845-54. PubMed ID: 25704311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.
    Tanaka T; Koie T; Ohyama C; Hashimoto Y; Imai A; Tobisawa Y; Hatakeyama S; Yamamoto H; Yoneyama T; Horiguchi H; Kodama H; Yoneyama T
    Jpn J Clin Oncol; 2017 Nov; 47(11):1078-1082. PubMed ID: 28973396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer incidentally discovered at the time of radical cystoprostatectomy does not decrease overall survival: Results from a large Chinese medical center.
    Tang S; Hao H; Fang D; Zheng W; Ge P; Su X; He Q; Yang X; Shen Q; Li X; Yu W; Lin J; Zhou L
    Int Braz J Urol; 2018; 44(2):258-266. PubMed ID: 29219277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.
    Pignot G; Salomon L; Neuzillet Y; Masson-Lecomte A; Lebacle C; Patard JJ; Lunardi P; Rischmann P; Pasticier G; Bernhard JC; Cohen J; Timsit MO; Verkarre V; Peyronnet B; Verhoest G; Le Goux C; Zerbib M; Brecheteau F; Bigot P; Larre S; Murez T; Thuret R; Lacarriere E; Champy C; Roupret M; Comperat E; Berger J; Descazeaud A; Toledano H; Bastide C; Lavilledieu S; Avances C; Delage F; Valeri A; Molimard B; Houlgatte A; Gres P; Donnaint A; Kleinclauss F; Legal S; Doerfler A; Koutlidis N; Cormier L; Hetet JF; Colls P; Arvin-Berod A; Rambeaud JJ; Quintens H; Soulie M; Pfister C;
    Ann Surg Oncol; 2014 Feb; 21(2):684-90. PubMed ID: 24170436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental prostate cancer in radical cystoprostatectomy specimens.
    Jin XD; Chen ZD; Wang B; Cai SL; Yao XL; Jin BY
    Asian J Androl; 2008 Sep; 10(5):809-14. PubMed ID: 18645685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic impact of incidental prostate cancer following radical cystoprostatectomy: a nationwide analysis.
    Jønck S; Helgstrand JT; Røder MA; Klemann N; Grønkaer Toft B; Brasso K
    Scand J Urol; 2018; 52(5-6):358-363. PubMed ID: 30624125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study.
    Rider JR; Sandin F; Andrén O; Wiklund P; Hugosson J; Stattin P
    Eur Urol; 2013 Jan; 63(1):88-96. PubMed ID: 22902040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-Analysis of 13,140 Patients.
    Fahmy O; Khairul-Asri MG; Schubert T; Renninger M; Stenzl A; Gakis G
    J Urol; 2017 Feb; 197(2):385-390. PubMed ID: 27569436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental prostate cancer at radical cystoprostatectomy: implications for apex-sparing surgery.
    Gakis G; Schilling D; Bedke J; Sievert KD; Stenzl A
    BJU Int; 2010 Feb; 105(4):468-71. PubMed ID: 20102366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis.
    Dell'Atti L
    Arch Ital Urol Androl; 2015 Mar; 87(1):76-9. PubMed ID: 25847902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental prostate cancer in patients undergoing radical cystoprostatectomy for bladder cancer.
    Hiros M; Spahović H; Selimović M; Sadović S
    Bosn J Basic Med Sci; 2008 May; 8(2):147-51. PubMed ID: 18498265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study.
    Stattin P; Sandin F; Thomsen FB; Garmo H; Robinson D; Lissbrant IF; Jonsson H; Bratt O
    Eur Urol; 2017 Jul; 72(1):125-134. PubMed ID: 27481175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
    Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
    Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of disease trajectory after radical treatment for high-risk prostate cancer.
    Stattin P; Fleming S; Lin X; Lefresne F; Brookman-May SD; Mundle SD; Pai H; Gifkins D; Robinson D; Styrke J; Garmo H
    BJU Int; 2024 Jul; 134(1):96-102. PubMed ID: 38621388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/mL undergoing radical cystoprostatectomy for bladder cancer in Iranian men.
    Hosseini SY; Danesh AK; Parvin M; Basiri A; Javadzadeh T; Safarinejad MR; Nahabedian A
    Int Braz J Urol; 2007; 33(2):167-73; discussion 173-5. PubMed ID: 17488535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.
    Revelo MP; Cookson MS; Chang SS; Shook MF; Smith JA; Shappell SB
    J Urol; 2004 Feb; 171(2 Pt 1):646-51. PubMed ID: 14713778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer.
    Delongchamps NB; Mao K; Theng H; Zerbib M; Debré B; Peyromaure M
    Eur Urol; 2005 Dec; 48(6):946-50. PubMed ID: 16126325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.